GENTIUM S R L has a total of 32 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are WEISENTHAL LARRY MARK, CT HOSPITALIER UNIVERSITAIRE MONTPELLIER and CHENGDU YIANBO BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United States | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Israel | 4 | |
#5 | Mexico | 2 | |
#6 | Singapore | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Taiwan | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Kumar Vijay | 14 |
#2 | Ignoni Terenzio | 14 |
#3 | Iacobelli Massimo | 9 |
#4 | Verga Claudio | 8 |
#5 | Islam Khalid | 6 |
#6 | Vijay Kumar | 4 |
#7 | Claudio Verga | 3 |
#8 | Terenzio Ignoni | 3 |
#9 | Stein Aaron Cy | 2 |
#10 | Porta Roberto | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019213053A1 | Methods for treating patients having sinusoidal obstruction syndrome | |
TW201520339A | Euglobulin-based method for determining the biological activity of defibrotide | |
SG10201705083RA | Euglobulin-based method for determining the biological activity of defibrotide |